NEWS

Sensome announces successful proof-of-concept adding its biological inte...

Sensome’s Clot‑Sensing Guidewire, Steered by Robocath’s Robotic Systems, Demonstrates Path Towards Physical AI 

A tribute to Eric Devineau

The best of LINNC Americas 2026

INR stories: Johanna Fifi's uncensored interview

Acandis GmbH Announces Start of Patient Recruitment for CARESTAR Study i...

Acandis GmbH, a leading German-based medical technology company specialising in medical devices for the treatment of neurovascular diseases, today announced the start of patient recruitment for the CARESTAR study following final positive approval from the responsible Ethics Committee. The study is registered on ClinicalTrials.gov (Identifier: NCT07166731).

Mastering complexity in wide-neck aneurysms, dissections and intracranial stenosis

M2 thrombectomy in a 91-year-old: decision-making in a high‑risk patient

Spinal perimedullary AVM: an advanced transvenous approach

Day 2 at LINNC Americas - Innovation Across Aneurysm, Stroke, AV Shunts, and Pediatric Neurointervention

Day 1 at LINNC Americas 2026: Live from Orlando